Clinical Software Pricing in Australian
Private Hospitals & Clinics

Australian private healthcare IT does not have a single pricing model — it has four, operating at different levels of the market with different dynamics. Per-practitioner subscription pricing is the dominant model for general practice management tools, where vendors compete on a transparent, monthly-per-doctor basis. This transparency is the result of commoditisation: when every named competitor publishes a per-seat rate, headline price becomes a comparison point and vendors must justify premium positioning through features rather than opacity.

Hospital information systems — Epic, Oracle Health, Alcidion, Telstra Health — operate under an entirely different regime. Pricing is bundled into multi-year enterprise contracts that include software licences, implementation services, ongoing support, and training. No Australian pricing is publicly disclosed by any of these vendors, and no procurement tender has surfaced contract values with enough granularity to reverse-engineer per-unit economics. The absence of published pricing is itself a structural advantage for incumbents: it raises the search cost for buyers and makes it harder for new entrants to undercut on price.

A third model — consumption-based or credit-based pricing — is emerging at the practice management layer. Halaxy charges AUD $0.15–$0.22 per transaction credit for services like SMS reminders, online bookings, and payment processing. [Halaxy] This hybrid approach — base subscription plus usage charges — mirrors the trajectory of SaaS pricing in adjacent markets (fintech, HR tech) and allows vendors to capture revenue from high-volume practices without raising the headline per-seat rate. The fourth model, perpetual licence, is fading from the general practice segment but may still exist in legacy hospital system contracts where upfront capital purchase was the norm before cloud migration.

The per-practitioner pricing band in Australian general practice management runs from AUD $35 (CorePlus) to $118.21 (Best Practice Software's Bp Premier, from July 2024). [Best Practice][CorePlus] That is a 3.4x spread from cheapest to most expensive named entry point — wide enough that price alone should be a significant differentiator, yet these vendors coexist because switching costs, Medicare integration reliability, and clinical workflow familiarity reduce price sensitivity at renewal. Practices rarely change their clinical software at contract end on price alone.

Best Practice Software's July 2024 pricing structure is the most granular publicly available data point in this market: Full Time Doctor at $118.21/month ($1,418.49/year) and Part Time at $59.10/month ($709.24/year), both ex GST, with volume discounts for multi-user and multi-site practices. [Best Practice] Halaxy's Growth tier is structured per-practitioner with pricing that scales from small clinics upward, while its Enterprise tier (30+ providers, multi-location) is custom-quoted. Zanda Health maps a broader range: $50–$350 per provider per month for small practices, $300–$1,200+ per month for mid-size, and $10,000–$100,000+ annually for enterprise. [Zanda]

Above this published layer, the market goes dark. Telstra Health, Alcidion, Epic, and Oracle Health — the vendors relevant to private hospital-grade deployments — publish no Australian pricing. This is not an oversight; it is a deliberate pricing strategy. Enterprise hospital software is sold through relationship-driven procurement cycles that can run 12–24 months, with pricing shaped by contract scope, integration complexity, bed count, and the competitive alternatives a buyer can credibly threaten to use. Listing a price would remove the negotiating surface that vendors use to price-discriminate across buyers of different sizes and urgency.

The per-practitioner model is clean for solo GPs and small clinics: one doctor, one monthly fee, predictable cost. It breaks down at scale. A private hospital with 80 admitting specialists does not have 80 users of a clinical information system in the same way a GP clinic has 80 GPs — clinical workflows involve nurses, administrative staff, ward clerks, and allied health practitioners, none of whom fit neatly into a per-doctor pricing unit. Vendors who persist with per-practitioner pricing at hospital scale are either forcing customers into awkward seat counting conversations, or they are quietly shifting to per-bed or per-episode metrics for larger contracts.

No Australian vendor publicly discloses a per-bed or per-episode model. But per-bed pricing is common in global hospital information system contracts — Epic's US pricing, widely reported in American procurement circles, is structured around site licences and per-bed annual fees, not per-seat counts. If Epic and Oracle Health are deploying into Australian private hospitals using their global pricing frameworks, per-bed or per-site models are likely operating here without public disclosure.

Outcomes-based pricing — where the vendor charges based on clinical outcomes achieved, readmissions avoided, or cost savings delivered — has been discussed in Australian Digital Health Agency strategy documents as a long-term direction. [ADHA] But no named vendor in the Australian private sector has publicly committed to an outcomes-based contract as of April 2026. The gap between strategic aspiration and commercial reality is large: outcomes measurement requires agreed data standards, attribution methodology, and audit capability that most private hospital operators do not yet have in place.

Among the vendors with published pricing, tier count ranges from two (Best Practice Software's Full-Time and Part-Time structure, with volume discounts as an implicit third tier) to three (Halaxy's Starter, Growth, Enterprise; Zanda Health's Small, Mid, Enterprise). CorePlus runs a deliberately simple flat entry price. The pattern is consistent with what Good-Better-Best architecture predicts: the entry tier is designed to be credible enough that a solo practitioner would choose it, but incomplete enough that any practice with growth ambitions upgrades.

The features that drive upgrades are not clinical — they are administrative and financial integrations. Telehealth modules, Medicare and DVA rebate processing, HICAPS (private health insurance claiming), NDIS billing, secure clinical messaging, and SMS patient engagement are the capabilities that push practices from entry to mid-tier. [Halaxy][Zanda] This matters for pricing strategy: the vendor's pricing problem is not convincing a GP that better scheduling software is worth $50 more per month. It is bundling the compliance and billing integrations that generate revenue for the practice into a tier that justifies the step-up.

For enterprise tiers — Halaxy's 30+ provider threshold, Zanda's $10,000+ annual custom tier — no published feature list defines what the upgrade delivers. This is deliberate. Enterprise pricing is a negotiation, not a catalogue. The published enterprise floor ($10,000/year for Zanda) exists to signal that the vendor has an enterprise offer; the actual price and scope are determined by what the buyer needs and what alternatives they have.

No customer survey, procurement tender result, or public disclosure reveals how Australian private hospital or clinic operators choose between pricing tiers, respond to discounts, or structure contract length preferences for clinical software. This is not a data collection failure — it is how the market is built. Private hospitals procure under commercial confidentiality. General practices are small businesses that do not report procurement decisions publicly. And no industry body in Australia collects or publishes aggregated data on clinical software spend per bed, per practice, or per episode.

The indirect evidence that does exist points to price inelasticity in procurement decisions rather than price sensitivity. Practices rarely switch clinical software at contract renewal on price alone — integration reliability, Medicare billing accuracy, and clinical familiarity carry more weight than a $20/month per-seat differential. [Best Practice] The 3.4x spread between CorePlus ($35/mo) and Best Practice Software ($118.21/mo) has persisted in a market where GPs could theoretically switch to the cheaper option at any renewal cycle. That it has not happened at scale suggests that headline price is not the primary buying criterion.

The one external pressure that may shift willingness to pay upward is private health insurance premium growth. PHI premiums rose 3.73% in 2025, [IHACPA] adding cost pressure to private hospital operators and clinic groups that rely on insurer revenue. As operator margins tighten, IT procurement budgets face scrutiny — which may accelerate the already-visible move toward SaaS subscription models (predictable OpEx) over enterprise perpetual licences (large CapEx) and push buyers to demand more granular per-use pricing so costs scale with volume rather than running at a fixed overhead.

No Australian procurement disclosure, tender result, or investor filing reveals the gap between list price and actual transaction price for clinical software in the private sector. This is consistent with global healthcare IT markets, where enterprise software discounts of 20–40% off list price are common in competitive deal situations, but no named Australian source confirms this range applies here. Treating it as fact without a named source would be fabrication — it is named here only as a global analogue, not an Australian finding.

For general practice management tools with published pricing, the list-to-transaction gap is likely small for individual practices — there is little negotiating leverage when a solo GP is choosing between a $35 and $118 per month tool. Volume discounts for multi-site groups are the primary mechanism by which published list prices are discounted, and Best Practice Software explicitly references multi-user and multi-site volume pricing in its published materials. [Best Practice] How large those discounts are is not published.

The buyers with the most leverage are the large private hospital groups — Ramsay Health Care, Healthscope, Calvary, and St Vincent's — who can credibly run a competitive tender across multiple enterprise vendors and threaten to switch platforms at contract renewal. These buyers are large enough that losing their contract would be material to a vendor's Australian revenue. Whether they use that leverage to extract meaningful discounts, or whether switching costs and integration lock-in neutralise their theoretical power, is not observable from public data. The KPMG Care Reimagined 2025 report noted that Australian health system operators face mounting cost pressure, [KPMG] but did not quantify IT procurement discount outcomes.

The direction of travel in Australian private healthcare IT pricing is from perpetual licence toward SaaS subscription, and from flat per-seat subscription toward hybrid models that combine a base fee with consumption charges. This mirrors the path taken by enterprise software in other sectors — ERP, HR tech, financial software — with a 3–5 year lag attributable to the higher switching costs, clinical risk aversion, and longer procurement cycles in healthcare.

The Australian Digital Health Agency's National Digital Health Strategy and Corporate Plan 2025–26 emphasise cloud-first deployment and interoperability as national priorities. [ADHA] Cloud-first mandates favour SaaS subscription economics over perpetual licence models, because cloud hosting is inherently a recurring cost. As private hospitals align with ADHA connectivity and data standards requirements, the infrastructure decisions that underpin pricing models shift in favour of subscription.

Consumption-based pricing is the logical next step once subscription is normalised — and Halaxy's credit model is the clearest evidence that at least one vendor has already made this move at the practice management layer. The question is whether hospital-grade vendors will follow. The answer depends on whether they can define a credible consumption unit — per-episode, per-admission, per-API call — that aligns with how private hospitals think about value. Per-episode pricing would directly connect software cost to clinical activity, which appeals to CFOs managing variable revenue from insurer contracts. No named vendor has announced this model for the Australian market as of April 2026.